Alpha Tau Medical Ltd. (DRTSW) SEC Filings — 2024

Filings

• Alpha Tau Medical to Present New Data at ASCO GI Symposium — 6-K · Dec 18, 2024
• Alpha Tau Medical Ltd. Elects New Directors — 6-K · Dec 17, 2024
• Alpha Tau Medical to Present at J.P. Morgan Healthcare Conference — 6-K · Dec 11, 2024
• Alpha Tau Medical to Present at Oncology Symposium — 6-K · Dec 6, 2024
• Alpha Tau Medical Reports Q3 2024 Results — 6-K · Nov 19, 2024
• Alpha Tau Medical to Present at Healthcare Conferences — 6-K · Nov 13, 2024
• Alpha Tau Medical Sets Shareholder Meeting for Dec 17 — 6-K · Nov 12, 2024
• Alpha Tau Medical Accepted into FDA TPLC Program — 6-K · Oct 21, 2024
• Alpha Tau Medical Treats First Recurrent Lung Cancer Patient — 6-K · Oct 10, 2024
• Alpha Tau Medical Gets FDA IDE for cSCC Study — 6-K · Sep 20, 2024
• Alpha Tau Medical to Present at Multiple Investor Conferences — 6-K · Aug 22, 2024
• Alpha Tau Medical Ltd. Files Interim Financials — 6-K · Aug 14, 2024
• Alpha Tau Medical Data Published in Cancers Journal — 6-K · Jun 25, 2024
• Alpha Tau Medical to Present at Jefferies Healthcare Conference — 6-K · May 21, 2024
• Alpha Tau Medical Reports Q1 2024 Results — 6-K · May 20, 2024
• Alpha Tau Treats First Liver Metastases Patient — 6-K · May 13, 2024
• Alpha Tau Medical Presents Pancreatic Cancer Preclinical Data — 6-K · May 6, 2024
• Alpha Tau Medical to Attend May Investor Conferences — 6-K · May 1, 2024
• Alpha Tau Medical to Present at Jefferies Radiopharma Summit — 6-K · Mar 25, 2024
• Alpha Tau Medical Reports 2022 Financials — 6-K · Mar 7, 2024
• Alpha Tau to Present at Barclays Global Healthcare Conference — 6-K · Feb 26, 2024